日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The gut-prostate axis in benign prostatic hyperplasia: systematic review of microbial dysbiosis and pathogenic mechanisms

良性前列腺增生中的肠-前列腺轴:微生物菌群失调和致病机制的系统性综述

Xu, Yuanzhao; An, Lingyue; Xie, Jiling; Luo, Chenggong; Huang, Xiaoxue; Luo, Guangheng

Investigating the impact of gut microbiota-derived metabolites on benign prostatic hyperplasia using network pharmacology approaches

利用网络药理学方法研究肠道菌群代谢产物对良性前列腺增生的影响

Xu, Yuanzhao; An, Lingyue; Xie, Jiling; Luo, Chenggong; Zhang, Heng; Zhang, Qinyi; Luo, Guangheng

Epithelial DPP4 promotes Ang II-driven renal fibrosis by targeting ACE2 activity in the renin-angiotensin system.

上皮细胞 DPP4 通过靶向肾素-血管紧张素系统中的 ACE2 活性来促进 Ang II 驱动的肾纤维化

Zhang Yingying, Tan Ruizhi, Wu Lehao, Zhao Dan, Zhong Cheng, Luo Chenggong, Chung Jeff Yat-Fai, Tang Patrick Ming-Kuen, Yu Chen

A modified strategy in robot-assisted laparoscopic partial nephrectomy for localized renal tuberculosis: the "unroofing and base excision" technique and clinical outcomes

机器人辅助腹腔镜下局部肾结核部分切除术的改良策略:“揭顶及基底部切除”技术及其临床疗效

Ban, Yong; Ma, Zehua; Liu, Di; Xiong, Min; Yue, Ting; An, Lingyue; Zhang, Qingyu; Liu, Hao; Luo, Chenggong; Li, Kai; Luo, Guangheng

Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma

布鲁顿酪氨酸激酶抑制剂保留抗 CD19 嵌合抗原受体 T 细胞功能并重新编程 B 细胞淋巴瘤中的肿瘤微环境

Wenjing Luo, Chenggong Li, Jianghua Wu, Lu Tang, Xindi Wang, Yinqiang Zhang, Zhuolin Wu, Zhongpei Huang, Jia Xu, Yun Kang, Wei Xiong, Jun Deng, Yu Hu, Heng Mei

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma

透明细胞肾细胞癌预后预测中的衰老相关基因特征

Li, Jiaying; Gui, Chengpeng; Yao, Haohua; Luo, Chenggong; Song, Hongde; Lin, Haishan; Xu, Quanhui; Chen, Xu; Huang, Yong; Luo, Junhang; Chen, Wei